chrX-111330914-G-A
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_ModerateBP6_Very_StrongBS2
The ENST00000358070.10(DCX):c.1111+5C>T variant causes a splice donor 5th base, intron change. The variant allele was found at a frequency of 0.0000611 in 1,210,288 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 18 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
ENST00000358070.10 splice_donor_5th_base, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DCX | NM_001195553.2 | c.936C>T | p.Asn312= | synonymous_variant | 5/7 | ENST00000636035.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DCX | ENST00000636035.2 | c.936C>T | p.Asn312= | synonymous_variant | 5/7 | 2 | NM_001195553.2 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000978 AC: 11AN: 112490Hom.: 0 Cov.: 23 AF XY: 0.0000866 AC XY: 3AN XY: 34644
GnomAD3 exomes AF: 0.0000601 AC: 11AN: 183085Hom.: 0 AF XY: 0.0000739 AC XY: 5AN XY: 67629
GnomAD4 exome AF: 0.0000574 AC: 63AN: 1097798Hom.: 0 Cov.: 31 AF XY: 0.0000413 AC XY: 15AN XY: 363200
GnomAD4 genome AF: 0.0000978 AC: 11AN: 112490Hom.: 0 Cov.: 23 AF XY: 0.0000866 AC XY: 3AN XY: 34644
ClinVar
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Apr 01, 2024 | DCX: BP4, BS2 - |
Benign, criteria provided, single submitter | clinical testing | Invitae | Nov 28, 2023 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 29, 2017 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at